A groundbreaking advancement in technology has emerged: scientists have developed a bio-computer using human cells. This ...

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the latest episode of ...

The FDA approved a T-cell therapy from Orca Bio that reduces the risk of a debilitating immune reaction in patients with ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...

Orca Bio has jumped into the commercial market with FDA approval for Tregzi, a first-of-its-kind engineered cell therapy for blood cancer patients requiring transplants.    | Orca Bio has jumped into ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...